Functional disaccharides: Lactulose, lactitol, and lactose

Handbook of Prebiotics and Probiotics Ingredients: Health Benefits and Food Applications

Volumn , Issue , 2009, Pages 95-122

  Szilagyi, Andrew ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACIDS;

CONTROLLED CONDITIONS; IN-VITRO; IN-VIVO; LACTITOL; LACTULOSE; PARENT COMPOUNDS; PREBIOTICS; SHORT-CHAIN FATTY ACIDS;

SUGARS;

EID: 84987841550     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (206)

1. Gibson, G.R. et al. Dietary modulation of the human colonic microbiota: Updating the concept of prebiotics, Nutr. Res. Rev., 17, 257, 2004.
2. Roberfroid, M., Prebiotics: The concept revisited, J. Nutr., 137, 830S, 2007.
3. Luz Sanz, M., Gibson, G.R., and Rastall, R.A. Influence of disaccharide structure on prebiotic selectivity in vitro, J. Agric. Food Chem., 53, 5192, 2005.
4. Tedelind, S. et al., Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: A study with relevance to inflammatory bowel disease, World J. Gastroenterol., 13, 2826, 2007.
5. Kivikoski, J. and Valkonen, J., Crystal structure of lactitol (4-O-β-d-galactopyranosyl-dglucitol) dihydrate, Carbohydr. Res., 223, 53, 1992.
6. Montgomery, E.M. and Hudson, C.S., Relationship between rotary power and structure in the sugar group XXVII. Synthesis of a new saccharide ketose (lactulose) from lactose, J. Am. Chem. Soc., 52, 2101, 1930.
7. Schumann, C., Medical, nutritional and technological properties of lactulose. An update, Eur. J. Nutr., 41(Suppl.) I/17, 2002.
8. Mayer, J., et al., Enzymatic production and complete nuclear magnetic resonance assignment of the sugar lactulose, J. Agric. Food. Chem., 52, 6983, 2004.
9. Huchzermeyer, H. and Schumann, C., Lactulose-A multifaceted substance, Z. Gastroenterol., 35, 945, 1997.
10. Clausen, M.R. and Mortensen, P.B., Lactulose, disaccharides and colonic flora, Drugs, 53, 930, 1997.
11. Jouet, P. et al., Low-dose lactulose produces a tonic contraction in the human colon, Neurogastroenterol. Motil., 18, 45, 2006.
12. Jouet, P. et al., Effects of therapeutic doses of lactulose vs polyethylene glycol on isotopic colonic transit, Aliment. Pharmacol. Ther., ahead of print PMID 18284652.
13. Pouteau, E. et al., Hydrogen production in dogs adapts to addition of lactulose and to a meat and rice diet, J. Nutr., 128, 2666S, 1998.
14. Flourie, B. et al., Can diarrhea induced by lactulose be reduced by prolonged ingestion of lactulose, Am. J. Clin. Nutr., 58, 369, 1993.
15. Gibson, G.R. and Roberfroid, M.B., Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics, J. Nutr., 125, 1401, 1995.
16. MacGillivray, P.C., Findlay, H.V.L., and Binns, T.B. Use of lactulose to create a preponderance of lactobacilli in the intestine of bottle-fed infants, Scot. Med. J., 4, 182, 1959.
17. Ballongue, J., Schumann, C., and Quignon, P. Effects of lactulose and lactitol on colonic microflora and enzyme activity, Scand. J. Gastroenterol. Suppl., 222, 41, 1997.
18. Terada, A. et al., Effect of lactulose on composition and metabolic activity of the human fecal flora. Microb. Ecol. Health. Dis., 5, 43, 1992.
19. Bouhnik, Y., et al., Lactulose ingestion increases faecal bifidobacterial counts: A randomised- double blind study on healthy humans. Eur. J. Clin. Nutr., 58, 462, 2004.
20. Bouhnik, Y. et al., The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: A double-blind, randomized placebo-controlled, parallelgroup, dose-response relation study, Am. J. Clin. Nutr., 80, 1658, 2004.
21. Vanhoutte, T. et al., Molecular monitoring of the fecal microbiota of healthy human subjects during administration of lactulose and Saccharomyces boulardii, Appl. Environ. Microbiol., 72, 5990, 2006.
22. De Preter, V. et al., Effect of dietary intervention with different pre-and probiotics on intestinal bacterial enzyme activities, Eur. J. Clin. Nutr., 62, 225, 2008.
23. Takada, H. et al., Effect of β-glucuronidase inhibitor on azoxymethane-induced colonic carcinogenesis in rats, Cancer Res., 42, 331, 1982.
24. Humblot, C. et al., β-Glucuronidase in human intestinal microbiota is necessary for the colonic genotoxicity of the food-borne carcinogen 2-amino-3-methylimidazo[4,5-f] quinoline in rats, Carcinogenesis, 28, 2419, 2007.
25. De Preter, V. et al., Influence of long-term administration of lactulose and Saccharomyces boulardii on the colonic generation of phenolic compounds in healthy human subjects, J. Am. Coll. Nutr., 25, 541, 2006.
26. Jouet, P. et al., Sugar intolerance: Origin and mechanisms of symptoms, Dig. Dis. Sci., 47, 886, 2002.
27. Sheikh, S.P., Neuropeptide YY: Major modulators of gastrointestinal blood flow and function, Am. J. Physiol., 261, G701, 1991.
28. Ropert, A. et al., Colonic fermentation and proximal gastric tone in humans, Gastroenterology, 111, 289, 1996.
29. Katayama, K., Ammonia metabolism and hepatic encephalopathy, Hepatol. Res., 30S, 73, 2004.
30. Orlandi, F. et al., Comparison between neomycin and lactulose in 173 patients with hepatic encephalopathy, Dig. Dis. Sci., 26, 498, 1981.
31. Prasad, S. et al., Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy, Hepatology, 45, 549, 2007.
32. Mortensen, P.B. et al., The degradation of amino acids, proteins, and blood to shortchain fatty acids in colon is prevented by lactulose, Gastroenterology, 98, 353, 1990.
33. Mortensen, P.B., The effect of oral-administered lactulose on colonic nitrogen metabolism and excretion, Hepatology, 16, 1350, 1992.
34. Bongaerts, G., Severijnen, R., and Timmerman, H., Effect of antibiotics, prebiotics and probiotics in treatment for hepatic encephalopathy, Med. Hypotheses, 64, 64, 2005.
35. Levine, M. and Hornick, R., Lactulose therapy in Shigella carrier state and acute dysentry, Antimicrob. Agent. Chemother., 8, 581, 1975.
36. Bovee-Oudenhoven, I.M.J. et al., Dietary fructo-oligosaccharides and lactulose inhibit intestinal colonisation but stimulate translocation of salmonella in rats, Gut, 52, 1572, 2003.
37. Pain, J.A. and Bailey, M.E., Experimental and clinical study of lactulose in obstructive jaundice, Br. J. Surg., 73, 775, 1986.
38. Liehr, H., Englisch, G., and Rasenack, U., Lactulose-A drug with antiendotoxin effect, Hepatogastroenterology, 27, 356, 1980.
39. Koutelidakis, I. et al., Systemic endotoxaemia following obstructive jaundice: The role of lactulose, J. Surg. Res., 113, 243, 2003.
40. van Vugt, H., van Gool, J., and Thomas, L.I., Galactosamine hepatitis, endotoxemia and lactulose, Hepatology, 3, 236, 1983.
41. Greve, J.W. et al., Lactulose inhibits endotoxin tumor necrosis factor production by monocytes. An in vitro study. Gut, 31, 198, 1990.
42. Conte, D. et al., Hypocholesterinemic effect of lactulose in man, Panminerva Med., 19, 1, 1977.
43. Rotstein, O.D. et al., Prevention of cholesterol gallstones by lignin and lactulose in the hamster, Gastroenterology, 81, 1098, 1981.
44. Vogt, J.A. et al., l-Rhamnose and lactulose decreases serum triacylglyerols and their rates of synthesis, but do not affect serum cholesterol concentrations in men, J. Nutr., 136, 2160, 2006.
45. Jenkins, D.J.A. et al., Specific types of colonic fermentation may raise low-densitylipoprotein- cholesterol concentrations, Am. J. Clin. Nutr., 54, 141, 1991.
46. Hosaka, H., Tokunaga, K., and Sakumoto, I., The influence of lactulose on intestinal absorption, Gastroenterol. Jpn., 7, 316, 1972.
47. Bianchi, G., Ronchi, M., and Marchesini, G., Effect of lactulose on carbohydrate metabolism and diabetes mellitus, Scand. J. Gastroenterol. Suppl., 222, 62, 1997.
48. Kirkman, M.S., Zimmerman, D.R., and Filippini, S.A., Marked deterioration in glycemic control with change in brand of lactulose syrup, South. Med. J., 88, 492, 1995.
49. Seki, N. et al., Effect of lactulose on calcium and magnesium absorption: A study using stable isotopes in adult men, J. Nutr. Sci. Vitaminol., 53, 5, 2007.
50. Van den Heuvel, E.G. et al., Lactulose stimulates calcium absorption in postmenopausal women, J. Bone Miner. Res., 14, 1211, 1999.
51. Beynen, A.C., Kappert, H.J., and Yu, S., Dietary lactulose decreases apparent nitrogen absorption and increases apparent calcium and magnesium absorption in healthy dogs, J. Anim. Physiol. a. Anim. Nutr., 85, 67, 2001.
52. Scholz-Ahreins, K.E. et al., Prebiotics, probiotics and synbiotics affect mineral absorption, bone mineral content, and bone structure, J. Nutr., 137, 838S, 2007.
53. Szilagyi, A., Rivard, J., and Fokeeff, K., Improved parameters of lactose maldigestion using lactulose, Dig. Dis. Sci., 46, 1509, 2001.
54. Szilagyi, A. et al., Deadaptation and readaptation with lactose, but no cross-adaptation to lactulose: A case of occult colonic bacterial adaptation, Can. J. Gastroenterol., 18, 677, 2004.
55. Fasano, A. and Shea-Donohue, T., Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases, Nat. Clin. Pract. Gastroenterol. Hepatol., 2, 416, 2005.
56. Demirogullari, B. et al., Effects of lactulose and lactitol on coliform bacteria and bacterial translocation in the caecum during 72-h starvation in rats, Comp. Biochem. Physiol. C. Toxicol. Pharmacol., 135C, 249, 2003.
57. McCutcheon, J. and Fulton, J.D., Lowered prevalence of infection with lactulose therapy in patients in continuing hospital care, J. Hosp. Infect., 13, 81, 1989.
58. Battle, M., Martin, T., and Fulton, J., Lactulose may help prevent urinary tract infections, Br. Med. J., 323, 936, 2001.
59. Wiest, R. and Garcia-Tsao, G., Bacterial translocation in cirrhosis, Hepatology, 41, 422, 2005.
60. Zhang, S. et al., Effects of lactulose on intestinal endotoxin and bacterial translocation in cirrhotic rats, Chin. Med. J., 116, 767, 2003.
61. Giovannucci, E., Metabolic syndrome, hyperinsulinemia, and colon cancer: A review, Am. J. Clin. Nutr., 86, s836, 2007.
62. MacFarlane, A.J. and Stover, P.J., Convergence of genetic, nutritional and inflammatory factors in gastrointestinal cancers, Nutr. Rev., 65, S157, 2007.
63. Hill, M.J. and Drasar, B.S., Degradation of bile salts by human intestinal bacteria, Gut, 9, 22, 1968.
64. Van Berge Henegouwen, G.P., van der Werf, S.D., and Ruben, A.T., Effect of long term lactulose ingestion on secondary bile salt metabolism in man: Potential protective effect of lactulose in colonic carcinogenesis, Gut, 28, 675, 1987.
65. Ingram, D.M. and Castleden, W.M., The effect of dietary lactulose on experimental large bowel cancer, Carcinogenesis, 1, 893, 1980.
66. Challa, A. et al., Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats, Carcinogenesis, 18, 517, 1997.
67. Lakatos, P.L. et al., Current concept on the pathogenesis of inflammatory bowel disease- crosstalk between genetic and microbial factors: Pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take toll? World J. Gastroenterol., 28, 1829, 2006.
68. Tamboli, C.P. et al., Dysbiosis in inflammatory bowel disease, Gut, 53, 1, 2004.
69. El Asmar, R. et al., Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure, Gastroenterology, 123, 1607, 2002.
70. Macfarlane, S. et al., Mucosal bacteria in ulcerative colitis, Br. J. Nutr., 93(Suppl.), S67, 2005.
71. Favier, C. et al., Fecal β-d-galactosidase production and bifidobacteria are decreased in Crohn’s disease, Dig. Dis. Sci., 42, 817, 1997.
72. Liao, W. et al., Lactulose-A potential drug for the treatment of inflammatory bowel disease, Med. Hypothes., 43, 234, 1990.
73. Madsen, K.L. et al., Lactobacillus species prevents colitis in interleukin-10 gene-deficient mice, Gastroenterology, 116, 1107, 1999.
74. Szilagyi, A., Rivard, J., and Shrier, I., Diminished efficacy of colonic adaptation to lactulose occurs in patients with inflammatory bowel disease in remission, Dig. Dis. Sci., 47, 2811, 2002.
75. Hafer, A. et al., Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: A pilot study. B.M.C. Gastroenterol., 7, 36, 2007.
76. Lindsay, J.O. et al., Clinical microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn’s disease, Gut, 55, 348, 2006.
77. Hirakawa, M. et al., Hydrogen breath test assessment of orocecal transit time: Comparison with barium meal study, Am. J. Gastroenterol., 83, 1361, 1988.
78. Sciarretta, G. et al., Lactulose hydrogen breath test in orocecal transit assessment. Critical evaluation by means of scintigraphic method, Dig. Dis. Sci., 39, 1505, 1994.
79. Tursi, A., Brandimarte, G., and Giorgetti, G.M., High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal, Am. J. Gastroenterol., 98, 839, 2003.
80. Dastych, M. et al., Lactulose/mannitol test and specificity, sensitivity, and area under curve of intestinal permeability parameters in patients with liver cirrhosis and Crohn’s disease, Dig. Dis. Sci., 2008, PMID: 18320320.
81. Fuji, T. et al., Lactulose-L0-rhamnose intestinal permeability test in patients with liver cirrhosis, Hepatol. Res., 19, 158, 2001.
82. Nelson, D.C., McGrew, W.R., Jr., and Hoyumpa, A.M., Jr., Hypernatremia and lactulose therapy, J.A.M.A., 249, 1295, 1983.
83. Nanji, A.A. and Lauener, R.W., Lactulose-induced hypernatremia, Drug Intell. Clin. Pharm., 18, 70, 1984.
84. Visser, L.E. et al., Overanticoagulation associated with combined use of lactulose and acenocoumarol or phenprocoumon, Br. J. Clin. Pharm., 57, 522, 2003.
85. Chauhan, N., Kamath, M., and Armstrong, D., Lactulose-induced reduction in parasympathetic autonomic neural activity: A mechanism for gastro-esophageal reflux (GER), Can. J. Gastroenterol., 22 (Suppl. A), 80A, 2008.
86. Goodman, R.A. and Riley, T.R., Lactulose induced pneumatosis intestinalis and pneumoperitoneum, Dig. Dis. Sci., 46, 2549, 2001.
87. Van Velthuijsen, J.A., Food additives derived from lactose: Lactitol and lactitol palmitate, J. Agric. Food Chem., 27, 680, 1979.
88. Patil, D.H. et al., Comparative modes of action of lactitol and lactulose in the treatment of hepatic encephalopathy, Gut, 28, 255, 1987.
89. Patil, D.H., Grimble, G.K., and Silk, D.B.A., Intestinal absorption and laxative threshold of lactitol-A new hydrogenated derivative of lactose, Gut, 26, A1114, 1985.
90. Dills, W.L., Jr., Sugar alcohols as bulk sweeteners, Annu. Rev. Nutr., 9, 161, 1989.
91. Oku, T., Nakamura, S., and Ichinose, M., Maximum permissive dose of lactose and lactitol for transitory diarrhea, and utilizable capacity for lactose in Japanese female adults, J. Nutr. Sci. Vitaminol., 51, 51, 2005.
92. Gee, J.M. and Johnson, I.T., Dietary lactitol fermentation increases circulating peptide YY and glucagon-like peptide-1 in rats and humans, Nutrition, 21, 1036, 2005.
93. Mortensen, P.B., Holtug, K., and Rasmussen, H.S., Short chain fatty acid production from and disaccharides in a fecal incubation system: Implications for colonic fermentation of dietary fiber in humans, J. Nutr., 118, 321, 1988.
94. Probert, H.M. et al., Polydextrose, lactitol, and fructo-oligosaccharide fermentation by colonic bacteria in a three-stage continuous culture system, Appl. Environ. Microbiol., 70, 4505, 2004.
95. Peuranen, S. et al., Combination of polydextrose and lactitol affects microbial ecosystem and immune response in rat gastrointestinal tract, Br. J. Nutr., 91, 905, 2004.
96. Finney, M. et al., Effects of low doses of lactitol on faecal microflora, pH, short chain fatty acids and gastrointestinal symptomatology, Eur. J. Nutr., 46, 307, 2007.
97. Nofrarias, M. et al., Long-term intake of resistant starch improves colonic mucosal integrity and reduces gut apoptosis and blood immune cells, Nutrition, 23, 861, 2007.
98. Daly, K. et al., The importance of colonic butyrate transport to the regulation of genes associated with colonic tissue, Biochem. Soc. Trans., 33, 733, 2005.
99. Sengupta, S., Muir, J.G., and Gibson, P.R., Does butyrate protect from colorectal cancer? J. Gastroenterol. Hepatol., 21, 209, 2006.
100. Pontes, F.A., Silva, A.T., and Cruz, A.C., Colonic transit times and the effects of lactulose or lactitol in hospitalized patients, Eur. J. Gastroenterol. Hepatol., 7, 441, 1995.
101. Pitzalis, G. et al., Lactitol in chronic idiopathic constipation in children, Pediatr. Med. Chir., 17, 223, 1995.
102. Nakamura, S. et al., Suppressive effects of partially hydrolized guar gum on transitory diarrhea induced by ingestion of maltitol and lactitol in healthy humans, Eur. J. Clin. Nutr., 61, 1086, 2007.
103. Lanthier, P.L. and Morgan, M.Y., Lactitol in the treatment of chronic hepatic encephalopathy: An open comparison with lactulose, Gut, 26, 415, 1985.
104. Mas, A. et al., Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: Results of a randomized, double-blind, double dummy, controlled clinical trial, J. Hepatol., 38, 51, 2003.
105. Camma, C. et al., Lactitol in the treatment of chronic hepatic encephalopathy. A metaanalysis, Dig. Dis. Sci., 38, 916, 1993.
106. Als-Nielsen, B., Gluud, L.L., and Gluud, C., Nonabsorbable disaccharides for hepatic encephalopathy, Cochrane Database Syst. Rev., 2, CD003044, 2004.
107. Ammann, P., Rizzoli, R., and Fleisch, H., Influence of the disaccharide lactitol on intestinal absorption and body retention of calcium in rats, J. Nutr., 118, 793, 1988.
108. Yanahira, S. et al., Effects of lactitol-oligosaccharides on calcium and magnesium absorption in rats, J. Nutr. Sci. Vitaminol., 43, 123, 1997.
109. Egger, B. et al., Effect of one month of lactitol treatment on calcium metabolism in man, Eur. J. Pharmacol., 37, 205, 1989.
110. Shimomura, Y. et al., Attenuated response of the serum triglyceride concentration to ingestion of a chocolate containing polydextrose and lactitol in place of sugar, Biosci. Biotechnol. Biochem., 69, 1819, 2005.
111. Chen, C. et al., Effects of lactitol on intestinal microflora and plasma endotoxin in patients with chronic viral hepatitis, J. Infect., 54, 98, 2007.
112. Buscaglia, C.A. et al., Trypanasoma cruzi surface mucins: Host-dependent coat diversity, Nat. Rev. Microbiol., 4, 229, 2006.
113. Augusti, R. et al., Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo, Glycobiology, 14, 659, 2004.
114. Grenby, T.H. and Phillips, A., Dental and metabolic effects of lactitol in the diet of laboratory rats, Br. J. Nutr., 61, 17, 1989.
115. Grenby, T.H., Latest state of research on lactitol and dental carries, Int. Dent. J., 39, 25, 1989.
116. van Loveren, C., Sugar alcohols: What is the evidence for caries-preventive and cariestherapeutic effects? Caries Res., 38, 286, 2004.
117. Park, J.Y. et al., A case of recurrent pneumatosis cystoides intestinalis associated with recurrent pneumoperitoneum [English abstract only], Korean J. Gastroenterol., 50, 188, 2007.
118. Prentice, D.E. and Meikle, A.W., A review of drug-induced Leydig cell hyperplasia and neoplasia in the rat and some comparison with man, Hum. Exp. Toxicol., 14, 562, 1995.
119. Vernia, P. et al., Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: Results of a multicentre trial, Eur. J. Clin. Invest., 33, 244, 2003.
120. Hallert, C. et al., Increasing fecal butyrate in ulcerative colitis patients by diet: Controlled pilot study, Inflamm. Bowel Dis., 9, 116, 2003.
121. Lupton, J.R., Microbial degradation products influence colon cancer risk: The butyrate controversy, J. Nutr., 134, 479, 2004.
122. Holt, P.R., Dairy foods and prevention of colon cancer: Human studies, J. Am. Coll. Nutr., 18, 379S, 1999.
123. Norat, T. and Riboli, E., Dairy products and colorectal cancer. A review of possible mechanisms and epidemiological evidence, Eur. J. Clin. Nutr., 57, 1, 2003.
124. Rowland, I.R., The effects of transgalactosylated oligosaccharides on gut flora metabolism in rats associated with a human faecal microflora, J. Appl. Bacteriol., 74, 667, 1993.
125. Ito, M. et al., Effects of transgalactosylated disaccharides on the human intestinal microflora and their metabolism, J. Nutr. Sci. Vitaminol., 39, 279, 1993.
126. Park, N.Y. et al., Production of a new sucrose derivative by transglycosylation of recombinant Sulfolobus shibatae beta-glycosidase, Carbohydr. Res., 340, 1089, 2005.
127. Lee, J.H. et al., Continuous production of lactosucrose by immobilized Sterigmatomyces elviae mutant, J. Microbiol. Biotechnol., 17, 1533, 2007.
128. Auricchio, S. et al., Isolated intestinal lactase deficiency in the adult, Lancet, 2, 324, 1963.
129. Gilat, T., Lactase deficiency: The world pattern today, Isr. J. Med. Sci., 15, 369, 1979.
130. Sahi, T. et al., Recessive inheritance of adult-type lactose malabsorption, Lancet, 2, 823, 1973.
131. Simoons, F.J., The geographic hypothesis and lactose malabsorption. A weighing of the evidence, Dig. Dis. Sci., 23, 963, 1978.
132. Anderson, B. and Vullo, C., Did malaria select for primary adult lactase deficiency? Gut, 35, 1487, 1994.
133. Flatz, G. and Rotthauwe, H.W., Lactose nutrition and natural selection, Lancet, 2, 76, 1973.
134. Gilat, T. et al., Lactase in man: A non adaptable enzyme, Gastroenterology, 62, 1125, 1972.
135. Kruse, T.A. et al., The human lactase-phlorizin gene is located on chromosome 2, FEBS Lett., 240, 123, 1988.
136. Kuokkanen, M. et al., Transcriptional regulation of the lactase-phlorizin hydrolase gene by polymorphisms associated with adult-type hypolactasia, Gut, 52, 647, 2003.
137. Ingram, C.J.E. et al., A novel polymorphism associated with lactose tolerance in Africa: Multiple causes for lactase persistence? Hum. Genet., 120, 779, 2007.
138. Sun, H.M. et al., The lactase gene-13910T allele cannot predict the lactase-persistence phenotype in north China, Asia Pac. J. Clin. Nutr., 16, 598, 2007.
139. Enattah, N.S. et al., Evidence of still-ongoing convergence evolution of the lactase persistence T-13910 alleles in humans, Am. J. Hum. Genet., 81, 615, 2007.
140. Maiuri, L. et al., Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia, Gastroenterology, 100, 123, 1991.
141. Rossi, M. et al., Lactase persistence versus decline in human adults: Multifactorial events are involved in down-regulation after weaning, Gastroenterology, 112, 1506, 1997.
142. Tursi, A. et al., Transient lactose malabsorption in patients affected by symptomatic uncomplicated diverticular disease of the colon, Dig. Dis. Sci., 51, 461, 2006.
143. Almeida, J.A. et al., Lactose malabsorption in the elderly: Role of small intestinal bacteria, Scand. J. Gastroenterol., 43, 146, 2008.
144. Pimmentel, M. et al., Breath testing to evaluate lactose intolerance in irritable bowel syndrome correlates with lactulose testing and may not reflect true lactose malabsorption, Am. J. Gastroenterol., 98, 2700, 2003.
145. Consumption statistics for milk and milk products 1989, Bull. Int. Dairy Federation, 254, 1, 1991.
146. Szilagyi, A., Review article: Lactose-a potential prebiotic, Aliment. Pharmacol. Ther., 16, 1591, 2002.
147. Bond, J.H. and Levitt, M.D., Quantitative measurement of lactose absorption, Gastroenterology, 70, 1058, 1976.
148. Sacerdote, C. et al., Lactase persistence and bitter taste response: Instrumental variables and Mendelian randomization in epidemiologic studies of dietary factors and cancer risk, Am. J. Epidemiol., 166, 576, 2007.
149. Scrimshaw, N.S. and Murray, E.B., The acceptability of milk and milk products in populations with high prevalence of lactose intolerance, Am. J. Clin. Nutr., 48S, 1079, 1988.
150. Kitts, D. et al., Adverse reactions to food constituents: Allergy, intolerance, and autoimmunity, Can. J. Physiol. Pharmacol., 75, 241, 1997.
151. Szilagyi, A., Salomon, R., and Seidman, E., Influence of Loperamide on lactose handling and oral caecal transit time, Aliment. Pharmacol. Ther., 10, 765, 1996.
152. Savaiano, D.A., Boushey, C.J., and McCabe, G.P., Lactose intolerance symptoms assessed by meta-analysis: A grain of truth that leads to exaggeration, J. Nutr., 136, 1107, 2006.
153. He, T. et al., Colonic fermentation may play a role in lactose intolerance in humans, J. Nutr., 136, 58, 2006.
154. He, T. et al., Effect of lactose on oro-cecal transit in lactose digesters and maldigesters, Eur. J. Clin. Invest., 36, 737, 2006.
155. Vesa, T.H., Korpela R.A., and Sahi, T., Tolerance to small amounts of lactose in lactose maldigesters, Am. J. Clin. Nutr., 64, 197, 1996.
156. Suarez, F.L., Savaiano, D.A., and Levitt, M.D., A comparison after the consumption of milk or lactose-hydrolyzed milk by people with self-reported severe lactose intolerance, N. Engl. J. Med., 333, 1, 1995.
157. Suarez, F.L. et al., Tolerance to the daily ingestion of two cups of milk by individuals claiming lactose intolerancer, Am. J. Clin. Nutr., 65, 1502, 1997.
158. Szilagyi, A. et al., Inverse dose effect of pretest dietary hydrogen results and symptoms in lactase nonpersistent subjects, Dig. Dis. Sci., 50, 2178, 2005.
159. Habte, D., Sterky, G., and Hjalmarsson, B. Lactose malabsorption in Ethiopian children, Acta Paediatr. Scand., 62, 649, 1973.
160. Sadre, M. and Karbasi, K., Lactose intolerance in Iran, Am. J. Clin. Nutr., 32, 1948, 1979.
161. Villar, J. et al., Improved lactose digestion during pregnancy: A case of physiologic adaptation? Obstet. Gynecol., 71, 697, 1988.
162. Szilagyi, A. et al., Lactose handling by women with lactose malabsorption is improved during pregnancy, Clin. Invest. Med., 19, 416, 1996.
163. Pribila, B.A. et al., Improved lactose digestion and intolerance among African-American adolescent girls fed a dairy-rich diet, J. Am. Diet. Assoc., 100, 524, 2000.
164. Hertzler, S.R. and Savaiano, D.A., Colonic adaptation to daily lactose feeding in lactose maldigesters reduces lactose intolerance, Am. J. Clin. Nutr., 64, 232, 1996.
165. Ladas, S., Papanikos, J., and Arapakis, G., Lactose malabsorption in Greek adults: Correlation of small bowel transit time with the severity of lactose intolerance, Gut, 23, 968, 1982.
166. Briet, F. et al., Improved clinical tolerance to chronic lactose ingestion in subjects with lactose intolerance: A placebo effect? Gut, 41, 632, 1997.
167. Briet, F. et al., Symptomatic response to varying levels of fructo-oligosaccharides consumed occasionally or regularly. Eur. J. Clin. Nutr., 49, 501, 1995.
168. Szilagyi, A. et al., Fructose malabsorption may be gender dependent and fails to show compensation by colonic adaptation, Dig. Dis. Sci., 52, 2999, 2007.
169. Hertzler, S.R., Savaiano, D.A., and Levitt, M.D., Fecal hydrogen production and consumption measurements. Response to daily lactose ingestion by lactose maldigesters, Dig. Dis. Sci., 42, 348, 1997.
170. He, T. et al., Identification of bacteria with β-galactosidae activity in faeces from lactase non-persistent subjects, F.E.M.S. Microbiol. Ecol., 54, 463, 2005.
171. Roy, K. et al., Metabolic adaptation of Lactococcus lactis in the digestive tract: The example of response to lactose, J. Mol. Microbiol. Biotechnol., 14, 137, 2008.
172. Saltzman, J.R. et al., A randomized trial of Lactobacillus acidophilus BG2FO4 to treat lactose intolerance, Am. J. Clin. Nutr., 69, 140, 1999.
173. Malolepszy, A., Shrier, I., and Szilagyi, A., Adaptation to lactose intolerance may not be achieved by long term ingestion of a multi-species containing probiotic: An extended preliminary study, Intern. J. Probiotics Prebiotics, 1, 113, 2006.
174. Tannock, G.W. et al., Impact of consumption of oligosaccharide-containing biscuits on fecal microbiota of humans, Appl. Environ. Microbiol., 70, 2129, 2004.
175. Jiang, T. and Savaiano, D.A., In vitro lactose fermentation by human colonic bacteria is modified by Lactobacillus acidophilus supplementation, J. Nutr., 1237, 1489, 1997.
176. Jiang, T. and Savaiano, D.A., Modification of colonic fermentation by bifidobacteria and pH in vitro. Impact on lactose metabolism, short-chain fatty acid, and lactate production, Dig. Dis. Sci., 42, 2370, 1997.
177. Makivuokko, H.A. et al., Effects of lactose on colon microbial community structure and function in a four-stage semi-continuous culture system, Biosci. Biotechnol. Biochem., 70, 2056, 2006.
178. Ito, M. and Kimura, M., Influence of lactose on faecal microflora in lactose maldigesters, Microb. Ecol. Health Dis., 6, 73, 1993.
179. Welsh, J.D. et al., Chronic hepatic encephalopathy treated with oral lactose in a patient with lactose malabsorption, N. Engl. J. Med., 291, 240, 1974.
180. Uribe, M. et al., Treatment of chronic portal-systemic encephalopathy with lactose in lactase-deficient patients, Dig. Dis. Sci, 25, 924, 1980.
181. Uribe, M. et al., Lactose enemas plus placebo tablets vs. neomycin tablets plus starch enemas in acute portal systemic encephalopathy; A double-blind randomized controlled study, Gastroenterology, 81, 101, 1981.
182. Lewis, H. et al., Similar effects of lactose and lactulose on in vitro fecal ammonia generation and bacterial flora (abstract), Gastroenterology, 78, 1206, 1980.
183. Vince, J. and Burridge, S.M., Ammonia production by intestinal bacteria: The effects of lactose, lactulose and glucose, J. Med. Microbiol., 13, 177, 1980.
184. Lengemann, F.W., The site of action of lactose in the enhancement of calcium utilization, J. Nutr., 69, 23, 1959.
185. Armbrecht, H.J. and Wasserman, R.H., Enhancement of Ca++ uptake by lactose in the rat small intestine, J. Nutr., 106, 1265, 1976.
186. Hamalainen, M.M. et al., Comparison of the effect of gluconate, lactose, and xylitol on bone recalcification in calcium-deficient rats, Bone, 11, 429, 1990.
187. Beynen, A.C. and Yu, S., Magnesium balance in adult cats fed a dry food rich in lactose, J. Anim. Physiol. Anim. Nutr., 87, 245, 2003.
188. Abrams, S.A., Griffin, I.J., and Davilla, P.M., Calcium and zinc absorption from lactosecontaining and lactose free infant formulas, Am. J. Clin. Nutr., 76, 442, 2002.
189. Cochet, B. et al., Effects of lactose on intestinal calcium absorption in normal and lactase-deficient subjects, Gastroenterology, 84, 935, 1983.
190. Zittermann, A. et al., Lactose does not enhance calcium bioavailability in lactose-tolerant, healthy adults, Am. J. Clin. Nutr., 71, 931, 2000.
191. Huang, Y. et al., Dietary intake of lactose as a strong predictor for secretor status of nipple aspirate fluid in healthy premenopausal nonlactating women, Clin. Cancer Res., 14, 1386, 2008.
192. Nanji, A.A and Denardi, F.G., Primary adult lactose intolerance protects against development of inflammatory bowel disease. Med. Hypotheses, 19, 1, 1986.
193. Cramer, D.W. and Xu, H., Lactase persistence, galactose metabolism and milk consumption as risk factors for ovarian cancer. In Common Food Intolerances 2: Milk in Human Nutrition and Adult-Type Hypolactasia. Auricchio, S. and Semenza, G., Eds., Karger, Basel, Switzerland, 1993, 52.
194. Shrier, I., Szilagyi, A., and Correa, J.A., Impact of lactose containing foods and the genetics of lactase on diseases: An analytical review of population data, Nutr. Cancer, 60, 292, 2008.
195. Szilagyi, A. et al., Evaluation of relationships among national colorectal cancer mortality rates, genetic lactase non persistence status and per capita yearly milk and milk product consumption, Nutr. Cancer, 55, 151, 2006.
196. Szilagyi, A. et al., The effect of lactose maldigestion on the relationship between dairy food intake and colorectal cancer: A systematic review. Nutr. Cancer, 55, 141, 2006.
197. Zhuo, X-G. and Watanabe, S., Factor analysis of digestive cancer mortality and food consumption in 65 Chinese counties, J. Epidemiol., 9, 275, 1999.
198. Alberts, D.S. et al., Randomized, double-blinded, placebo-controlled study of effect of wheat bran fiber and calcium on fecal bile acids in patients with resected adenomatous polyps, J. Natl. Cancer Inst., 88, 81, 1996.
199. Weingarten, M.A., Zalmanovici, A., and Yaphe, J., Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps, Cochrane Database Syst. Rev, 23, CD003546, 2008.
200. Flood, A., Calcium from diet and supplements is associated with reduced risk of colorectal cancer in a prospective cohort of women, Cancer Epidemiol. Biomarkers Prev., 14, 126, 2005.
201. Shin, A. et al., Dietary intake of calcium, fiber and other micronutrients in relation to colorectal cancer risk: Results from Shanghai women’s health study, Int. J. Cancer, 119, 2938, 2006.
202. He, Y. et al., Status of dietary calcium intake of Chinese residents [abstract available in English], Wei Sheng Yan Jiu, 36, 600, 2007.
203. Park, S-Y. et al., Calcium and vitamin D intake and risk of colorectal cancer: The multiethnic cohort study, Am. J. Epidemiol., 165,784, 2007.
204. Jemal, A. et al., Cancer statistics, 2008, C.A. Cancer J. Clin., 58, 71, 2008.
205. Kolonel, L.N. et al., A multiethnic cohort in Hawaii and Los Angeles: Baseline characteristics, Am. J. Epidemiol., 151, 346, 2000.
206. Segall, J.J., Dietary lactose as a possible risk factor for ischemic heart disease: Review of epidemiology, Int. J. Cardiol., 46, 197, 1994.